Terms: = Endocrine gland cancer AND MS4A1, B1, Bp35, CD20, CVID5, LEU-16, MS4A2, S7 AND Treatment
225 results:
1. 5 signature genes revealed by single-cell profiling identified unique immune subtypes affecting the prognosis of ovarian cancer.
Xiang SY; Li QK; Yang Z; Yi Q
Eur Rev Med Pharmacol Sci; 2024 Mar; 28(5):2051-2062. PubMed ID: 38497886
[TBL] [Abstract] [Full Text] [Related]
2. Evidence of the Role of Inflammation and the Hormonal Environment in the Pathogenesis of Adrenal Myelolipomas in Congenital Adrenal Hyperplasia.
Kolli V; Frucci E; da Cunha IW; Iben JR; Kim SA; Mallappa A; Li T; Faucz FR; Kebebew E; Nilubol N; Quezado MM; Merke DP
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473790
[TBL] [Abstract] [Full Text] [Related]
3. FBXO28 promotes cell proliferation, migration and invasion via upregulation of the TGF-beta1/SMAD2/3 signaling pathway in ovarian cancer.
Song G; Sun Z; Chu M; Zhang Z; Chen J; Wang Z; Zhu X
BMC Cancer; 2024 Jan; 24(1):122. PubMed ID: 38267923
[TBL] [Abstract] [Full Text] [Related]
4. Nanoparticle Targeting in Chemo-Resistant Ovarian cancer Reveals Dual Axis of Therapeutic Vulnerability Involving Cholesterol Uptake and Cell Redox Balance.
Wang Y; Calvert AE; Cardenas H; Rink JS; Nahotko D; Qiang W; Ndukwe CE; Chen F; Keathley R; Zhang Y; Cheng JX; Thaxton CS; Matei D
Adv Sci (Weinh); 2024 Apr; 11(13):e2305212. PubMed ID: 38263873
[TBL] [Abstract] [Full Text] [Related]
5. Inhibition of Drp1 orchestrates the responsiveness of breast cancer cells to paclitaxel but insignificantly relieves paclitaxel-related ovarian damage in mice.
Alalawy AI; Sakran M; Alzuaibr FM; Alotaibi MA; El-Hefnawy ME; Hazazi AY; El-Gendy SM; Aidy EA; Effat H; Ismail DF; Hessien M
Sci Rep; 2023 Dec; 13(1):22782. PubMed ID: 38129495
[TBL] [Abstract] [Full Text] [Related]
6. Hydrogen Peroxide Mediates Pharmacological Ascorbate Induced Radio-Sensitization of Pancreatic cancer Cells by Enhancing G2-accumulation and Reducing Cyclin B1 Protein Levels.
O'Leary BR; Kalen AL; Pope AN; Goswami PC; Cullen JJ
Radiat Res; 2023 Nov; 200(5):444-455. PubMed ID: 37758045
[TBL] [Abstract] [Full Text] [Related]
7. Initial Evaluation of [
Watabe T; Naka S; Tatsumi M; Kamiya T; Kimura T; Shintani Y; Abe K; Miyake T; Shimazu K; Kobayashi S; Kurokawa Y; Eguchi H; Doki Y; Inohara H; Kato H; Mori Y; Cardinale J; Giesel FL
J Nucl Med; 2023 Aug; 64(8):1225-1231. PubMed ID: 37268427
[TBL] [Abstract] [Full Text] [Related]
8. A hybrid nanopharmaceutical for specific-amplifying oxidative stress to initiate a cascade of catalytic therapy for pancreatic cancer.
Liu F; Xiang Q; Luo Y; Luo Y; Luo W; Xie Q; Fan J; Ran H; Wang Z; Sun Y
J Nanobiotechnology; 2023 May; 21(1):165. PubMed ID: 37221521
[TBL] [Abstract] [Full Text] [Related]
9. CD68+ and CD8+ immune cells are associated with the growth pattern of somatotroph tumors and response to first generation somatostatin analogs.
Chiloiro S; Giampietro A; Gessi M; Lauretti L; Mattogno PP; Cerroni L; Carlino A; De Alessandris QG; Olivi A; Rindi G; Pontecorvi A; De Marinis L; Doglietto F; Bianchi A
J Neuroendocrinol; 2023 Apr; 35(4):e13263. PubMed ID: 37078422
[TBL] [Abstract] [Full Text] [Related]
10. Mechanistic insights of NAC1 nuclear export and its role in ovarian cancer resistance to docetaxel.
Dong S; Wang X; Yang S; Guo F; Zhang J; Ji C; Shi L; Cheng Y; Hu Y; Li Z; Peng L; Guo L; Zhu W; Ren X; Yang JM; Zhang Y
Biochem Pharmacol; 2023 May; 211():115533. PubMed ID: 37019189
[TBL] [Abstract] [Full Text] [Related]
11. Tumor immune microenvironment changes are associated with response to neoadjuvant chemotherapy and long-term survival benefits in advanced epithelial ovarian cancer: A pilot study.
Cao G; Hua D; Li J; Zhang X; Zhang Z; Zhang B; Bei T; Cui L; Chen S; Wang S; Zhu L
Front Immunol; 2023; 14():1022942. PubMed ID: 36993949
[TBL] [Abstract] [Full Text] [Related]
12. Combined treatment with
Huang S; Cui M; Wang R; Yang G; Wang N; Cui L; Ma G
Nucleosides Nucleotides Nucleic Acids; 2023; 42(9):731-742. PubMed ID: 36924446
[TBL] [Abstract] [Full Text] [Related]
13. Follicular pancreatitis: Case report and literature review.
Lee WS; Kim KH; Noh MG; Joo YE
Medicine (Baltimore); 2023 Feb; 102(5):e32837. PubMed ID: 36749228
[TBL] [Abstract] [Full Text] [Related]
14. Adrenocortical carcinoma metastasis. A long story.
Mascioli F; Ossola P; Esposito L; Ascione A; De Gyurgyokai SZ
Ann Ital Chir; 2022 Dec; 11():. PubMed ID: 36655977
[TBL] [Abstract] [Full Text] [Related]
15. X-linked inhibitor of apoptosis protein is a prognostic marker for a favorable outcome in three identified subsets in resectable adenocarcinoma of the pancreas.
Knipper K; Lyu SI; Goebel H; Damanakis AI; Zhao Y; Bruns CJ; Schmidt T; Kashkar H; Quaas A; Schiffmann LM; Popp FC;
J Cancer Res Clin Oncol; 2023 Aug; 149(9):5531-5538. PubMed ID: 36472768
[TBL] [Abstract] [Full Text] [Related]
16. Gomisin A enhances the antitumor effect of paclitaxel by suppressing oxidative stress in ovarian cancer.
Wang T; Liu J; Huang X; Zhang C; Shangguan M; Chen J; Wu S; Chen M; Yang Z; Zhao S
Oncol Rep; 2022 Nov; 48(5):. PubMed ID: 36169181
[TBL] [Abstract] [Full Text] [Related]
17. Identification and verification of CCNB1 as a potential prognostic biomarker by comprehensive analysis.
Zeng Y; Fan R
Sci Rep; 2022 Sep; 12(1):16153. PubMed ID: 36167975
[TBL] [Abstract] [Full Text] [Related]
18. Preclinical assessment of synergistic efficacy of MELK and CDK inhibitors in adrenocortical cancer.
Laha D; Grant RRC; Mishra P; Boufraqech M; Shen M; Zhang YQ; Hall MD; Quezado M; De Melo MS; Del Rivero J; Zeiger M; Nilubol N
J Exp Clin Cancer Res; 2022 Sep; 41(1):282. PubMed ID: 36151566
[TBL] [Abstract] [Full Text] [Related]
19. IgG
Couto N; Elzanowska J; Maia J; Batista S; Pereira CE; Beck HC; Carvalho AS; Strano Moraes MC; Carvalho C; Oliveira M; Matthiesen R; Costa-Silva B
Cells; 2022 Sep; 11(18):. PubMed ID: 36139375
[TBL] [Abstract] [Full Text] [Related]
20. Epigenetic priming enhances antitumor immunity in platinum-resistant ovarian cancer.
Chen S; Xie P; Cowan M; Huang H; Cardenas H; Keathley R; Tanner EJ; Fleming GF; Moroney JW; Pant A; Akasha AM; Davuluri RV; Kocherginsky M; Zhang B; Matei D
J Clin Invest; 2022 Jul; 132(14):. PubMed ID: 35671108
[TBL] [Abstract] [Full Text] [Related]
[Next]